Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 132

1.

Major ischaemic and bleeding risks following current drug-eluting stent implantation: Are there differences across current drug-eluting stent types in real life?

Schapiro-Dufour E, Tricotel A, Slama MS, Ducimetière P, Trinh-Duc A, Sichel C, Le Tri T, Galmiche H, Dray-Spira R, Zureik M.

Arch Cardiovasc Dis. 2019 Jun 28. pii: S1875-2136(19)30101-9. doi: 10.1016/j.acvd.2019.04.007. [Epub ahead of print]

PMID:
31262635
2.

Risks of 23 specific malformations associated with prenatal exposure to 10 antiepileptic drugs.

Blotière PO, Raguideau F, Weill A, Elefant E, Perthus I, Goulet V, Rouget F, Zureik M, Coste J, Dray-Spira R.

Neurology. 2019 Jul 9;93(2):e167-e180. doi: 10.1212/WNL.0000000000007696. Epub 2019 Jun 12.

PMID:
31189695
3.

Comment on: "Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?"

Coste J, Bertagna X, Zureik M.

Clin Pharmacokinet. 2019 Jul;58(7):965-966. doi: 10.1007/s40262-019-00779-9. No abstract available.

PMID:
31161457
4.

Evaluation of the Incidence of Hematologic Malignant Neoplasms Among Breast Cancer Survivors in France.

Jabagi MJ, Vey N, Goncalves A, Le Tri T, Zureik M, Dray-Spira R.

JAMA Netw Open. 2019 Jan 4;2(1):e187147. doi: 10.1001/jamanetworkopen.2018.7147.

5.

Reply to the Letter to the Editor: Is There a Cardiotoxicity Associated With Metallic Head Hip Prostheses? A Cohort Study in the French National Health Insurance Databases.

Lassalle M, Colas S, Zureik M, Dray-Spira R.

Clin Orthop Relat Res. 2018 Dec;476(12):2462-2463. doi: 10.1097/CORR.0000000000000525. No abstract available.

PMID:
30427317
6.

Risk of hospitalisation and death related to baclofen for alcohol use disorders: Comparison with nalmefene, acamprosate, and naltrexone in a cohort study of 165 334 patients between 2009 and 2015 in France.

Chaignot C, Zureik M, Rey G, Dray-Spira R, Coste J, Weill A.

Pharmacoepidemiol Drug Saf. 2018 Nov;27(11):1239-1248. doi: 10.1002/pds.4635. Epub 2018 Sep 25.

7.

Antidepressants and Hepatotoxicity: A Cohort Study among 5 Million Individuals Registered in the French National Health Insurance Database.

Billioti de Gage S, Collin C, Le-Tri T, Pariente A, Bégaud B, Verdoux H, Dray-Spira R, Zureik M.

CNS Drugs. 2018 Jul;32(7):673-684. doi: 10.1007/s40263-018-0537-1.

8.

Thromboembolic risk after lumbar spine surgery: a cohort study on 325 000 French patients.

Bouyer B, Rudnichi A, Dray-Spira R, Zureik M, Coste J.

J Thromb Haemost. 2018 Jun 12. doi: 10.1111/jth.14205. [Epub ahead of print]

PMID:
29893460
9.

Smart watches for heart rate assessment in atrial arrhythmias.

Koshy AN, Sajeev JK, Nerlekar N, Brown AJ, Rajakariar K, Zureik M, Wong MC, Roberts L, Street M, Cooke J, Teh AW.

Int J Cardiol. 2018 Sep 1;266:124-127. doi: 10.1016/j.ijcard.2018.02.073.

PMID:
29887428
10.

Statins for primary prevention and rhabdomyolysis: A nationwide cohort study in France.

Coste J, Billionnet C, Rudnichi A, Pouchot J, Dray-Spira R, Giral P, Zureik M.

Eur J Prev Cardiol. 2019 Mar;26(5):512-521. doi: 10.1177/2047487318776831. Epub 2018 May 25.

PMID:
29799296
11.

Development of an algorithm to identify pregnancy episodes and related outcomes in health care claims databases: An application to antiepileptic drug use in 4.9 million pregnant women in France.

Blotière PO, Weill A, Dalichampt M, Billionnet C, Mezzarobba M, Raguideau F, Dray-Spira R, Zureik M, Coste J, Alla F.

Pharmacoepidemiol Drug Saf. 2018 Jul;27(7):763-770. doi: 10.1002/pds.4556. Epub 2018 May 15.

12.

Utility of photoplethysmography for heart rate estimation among inpatients.

Koshy AN, Sajeev JK, Nerlekar N, Brown AJ, Rajakariar K, Zureik M, Wong MC, Roberts L, Street M, Cooke J, Teh AW.

Intern Med J. 2018 May;48(5):587-591. doi: 10.1111/imj.13777.

PMID:
29722189
13.

Is There a Cardiotoxicity Associated With Metallic Head Hip Prostheses? A Cohort Study in the French National Health Insurance Databases.

Lassalle M, Colas S, Rudnichi A, Zureik M, Dray-Spira R.

Clin Orthop Relat Res. 2018 Jul;476(7):1441-1451. doi: 10.1097/01.blo.0000533617.64678.69.

14.

Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases.

Kirchgesner J, Lemaitre M, Carrat F, Zureik M, Carbonnel F, Dray-Spira R.

Gastroenterology. 2018 Aug;155(2):337-346.e10. doi: 10.1053/j.gastro.2018.04.012. Epub 2018 Apr 12.

PMID:
29655835
15.

Association of Hysteroscopic vs Laparoscopic Sterilization With Procedural, Gynecological, and Medical Outcomes.

Bouillon K, Bertrand M, Bader G, Lucot JP, Dray-Spira R, Zureik M.

JAMA. 2018 Jan 23;319(4):375-387. doi: 10.1001/jama.2017.21269.

16.

Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease.

Lemaitre M, Kirchgesner J, Rudnichi A, Carrat F, Zureik M, Carbonnel F, Dray-Spira R.

JAMA. 2017 Nov 7;318(17):1679-1686. doi: 10.1001/jama.2017.16071.

17.

Relative impact of hospital and surgeon procedure volumes on primary total hip arthroplasty revision: a nationwide cohort study in France.

Cossec CL, Colas S, Zureik M.

Arthroplast Today. 2017 Jun 21;3(3):176-182. doi: 10.1016/j.artd.2017.03.010. eCollection 2017 Sep.

18.

Human papillomavirus vaccination and risk of autoimmune diseases: A large cohort study of over 2million young girls in France.

Miranda S, Chaignot C, Collin C, Dray-Spira R, Weill A, Zureik M.

Vaccine. 2017 Aug 24;35(36):4761-4768. doi: 10.1016/j.vaccine.2017.06.030. Epub 2017 Jul 24.

19.

Exchangeable Femoral Neck (Dual-Modular) THA Prostheses Have Poorer Survivorship Than Other Designs: A Nationwide Cohort of 324,108 Patients.

Colas S, Allalou A, Poichotte A, Piriou P, Dray-Spira R, Zureik M.

Clin Orthop Relat Res. 2017 Aug;475(8):2046-2059. doi: 10.1007/s11999-017-5260-6. Epub 2017 Feb 13.

20.
21.

Therapeutic management of inflammatory bowel disease in real-life practice in the current era of anti-TNF agents: analysis of the French administrative health databases 2009-2014.

Kirchgesner J, Lemaitre M, Rudnichi A, Racine A, Zureik M, Carbonnel F, Dray-Spira R.

Aliment Pharmacol Ther. 2017 Jan;45(1):37-49. doi: 10.1111/apt.13835. Epub 2016 Oct 26.

22.

Oral Fluoroquinolone Use and Retinal Detachment-Reply.

Raguideau F, Dray-Spira R, Zureik M.

JAMA Ophthalmol. 2016 Dec 1;134(12):1448-1449. doi: 10.1001/jamaophthalmol.2016.3479. No abstract available.

PMID:
27768169
23.

Association between Exposure to Benzodiazepines and Related Drugs and Survivorship of Total Hip Replacement in Arthritis: A Population-Based Cohort Study of 246,940 Patients.

Beziz D, Colas S, Collin C, Dray-Spira R, Zureik M.

PLoS One. 2016 May 24;11(5):e0155783. doi: 10.1371/journal.pone.0155783. eCollection 2016.

24.

Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study.

Weill A, Dalichampt M, Raguideau F, Ricordeau P, Blotière PO, Rudant J, Alla F, Zureik M.

BMJ. 2016 May 10;353:i2002. doi: 10.1136/bmj.i2002.

25.

Association Between Oral Fluoroquinolone Use and Retinal Detachment.

Raguideau F, Lemaitre M, Dray-Spira R, Zureik M.

JAMA Ophthalmol. 2016 Apr;134(4):415-21. doi: 10.1001/jamaophthalmol.2015.6205.

PMID:
26967005
26.

Risk of bleeding and arterial thromboembolism in patients with non-valvular atrial fibrillation either maintained on a vitamin K antagonist or switched to a non-vitamin K-antagonist oral anticoagulant: a retrospective, matched-cohort study.

Bouillon K, Bertrand M, Maura G, Blotière PO, Ricordeau P, Zureik M.

Lancet Haematol. 2015 Apr;2(4):e150-9. doi: 10.1016/S2352-3026(15)00027-7. Epub 2015 Apr 1.

PMID:
26687957
27.

Association Between Total Hip Replacement Characteristics and 3-Year Prosthetic Survivorship: A Population-Based Study.

Colas S, Collin C, Piriou P, Zureik M.

JAMA Surg. 2015 Oct;150(10):979-88. doi: 10.1001/jamasurg.2015.1325.

PMID:
26288068
28.

Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort study.

Maura G, Blotière PO, Bouillon K, Billionnet C, Ricordeau P, Alla F, Zureik M.

Circulation. 2015 Sep 29;132(13):1252-60. doi: 10.1161/CIRCULATIONAHA.115.015710. Epub 2015 Jul 21.

29.

Impact of the sharp changes in the use of contraception in 2013 on the risk of pulmonary embolism in France.

Tricotel A, Collin C, Zureik M.

J Thromb Haemost. 2015 Sep;13(9):1576-80. doi: 10.1111/jth.13053. Epub 2015 Jul 31.

30.

Compliance with pregnancy prevention plan recommendations in 8672 French women of childbearing potential exposed to acitretin.

Raguideau F, Mezzarobba M, Zureik M, Weill A, Ricordeau P, Alla F.

Pharmacoepidemiol Drug Saf. 2015 May;24(5):526-33. doi: 10.1002/pds.3763. Epub 2015 Mar 9.

PMID:
25753265
31.

Impact of the 2013 French Pill Crisis on Women's Behaviour Regarding Contraception.

Lemaitre M, Lastennet G, Syr D, Emmerich J, Zureik M.

Drugs Real World Outcomes. 2015 Mar;2(1):13-22. Review.

32.

Carotid plaque as a predictor of dementia in older adults: the Three-City Study.

Carcaillon L, Plichart M, Zureik M, Rouaud O, Majed B, Ritchie K, Tzourio C, Dartigues JF, Empana JP.

Alzheimers Dement. 2015 Mar;11(3):239-48. doi: 10.1016/j.jalz.2014.07.160. Epub 2014 Dec 12.

PMID:
25510384
33.

A clinical in-hospital prognostic score for acute exacerbations of COPD.

Roche N, Chavaillon JM, Maurer C, Zureik M, Piquet J.

Respir Res. 2014 Aug 27;15:99. doi: 10.1186/s12931-014-0099-9.

34.

Contraceptive pills and thrombosis: effects of the French crisis on prescriptions and consequences for medicine agencies.

Emmerich J, Thomassin C, Zureik M.

J Thromb Haemost. 2014 Sep;12(9):1388-90. doi: 10.1111/jth.12661. Epub 2014 Aug 13.

35.

Estimate of venous thromboembolism and related-deaths attributable to the use of combined oral contraceptives in France.

Tricotel A, Raguideau F, Collin C, Zureik M.

PLoS One. 2014 Apr 21;9(4):e93792. doi: 10.1371/journal.pone.0093792. eCollection 2014.

36.

Does omalizumab make a difference to the real-life treatment of asthma exacerbations?: Results from a large cohort of patients with severe uncontrolled asthma.

Grimaldi-Bensouda L, Zureik M, Aubier M, Humbert M, Levy J, Benichou J, Molimard M, Abenhaim L; Pharmacoepidemiology of Asthma and Xolair (PAX) Study Group.

Chest. 2013 Feb 1;143(2):398-405. doi: 10.1378/chest.12-1372.

PMID:
23505637
37.

Large-vessel correlates of cerebral small-vessel disease.

Brisset M, Boutouyrie P, Pico F, Zhu Y, Zureik M, Schilling S, Dufouil C, Mazoyer B, Laurent S, Tzourio C, Debette S.

Neurology. 2013 Feb 12;80(7):662-9. doi: 10.1212/WNL.0b013e318281ccc2. Epub 2013 Jan 23.

38.

Gender differences in prevalence, diagnosis and incidence of allergic and non-allergic asthma: a population-based cohort.

Leynaert B, Sunyer J, Garcia-Esteban R, Svanes C, Jarvis D, Cerveri I, Dratva J, Gislason T, Heinrich J, Janson C, Kuenzli N, de Marco R, Omenaas E, Raherison C, Gómez Real F, Wjst M, Zemp E, Zureik M, Burney PG, Anto JM, Neukirch F.

Thorax. 2012 Jul;67(7):625-31. doi: 10.1136/thoraxjnl-2011-201249. Epub 2012 Feb 14.

PMID:
22334535
39.

Estimate of deaths due to valvular insufficiency attributable to the use of benfluorex in France.

Fournier A, Zureik M.

Pharmacoepidemiol Drug Saf. 2012 Apr;21(4):343-51. doi: 10.1002/pds.3213. Epub 2012 Feb 9.

PMID:
22318872
40.

Chronic bronchitis in the general population: influence of age, gender and socio-economic conditions.

Ferré A, Fuhrman C, Zureik M, Chouaid C, Vergnenègre A, Huchon G, Delmas MC, Roche N.

Respir Med. 2012 Mar;106(3):467-71. doi: 10.1016/j.rmed.2011.12.002. Epub 2011 Dec 23.

41.

Abdominal obesity and late-onset asthma: cross-sectional and longitudinal results: the 3C study.

Leone N, Courbon D, Berr C, Barberger-Gateau P, Tzourio C, Alpérovitch A, Zureik M.

Obesity (Silver Spring). 2012 Mar;20(3):628-35. doi: 10.1038/oby.2011.308. Epub 2011 Oct 20.

42.

Carotid intima-media thickness in plaque-free site, carotid plaques and coronary heart disease risk prediction in older adults. The Three-City Study.

Plichart M, Celermajer DS, Zureik M, Helmer C, Jouven X, Ritchie K, Tzourio C, Ducimetière P, Empana JP.

Atherosclerosis. 2011 Dec;219(2):917-24. doi: 10.1016/j.atherosclerosis.2011.09.024. Epub 2011 Sep 28.

PMID:
22005196
43.

Five-year survival for lung cancer patients managed in general hospitals.

Grivaux M, Zureik M, Marsal L, Asselain B, Peureux M, Chavaillon JM, Prudhomme A, Carbonnelle M, Goarant E, Maury B, Bedossa A, Blanchon F.

Rev Mal Respir. 2011 Sep;28(7):e31-8. doi: 10.1016/j.rmr.2008.07.001. Epub 2011 Aug 2.

PMID:
21943545
44.

[Study KBP-2010-CPHG: inclusion of new cases of primary lung cancer diagnosed in general hospital pneumology departments between 1st January and 31 December 2010].

Grivaux M, Locher C, Bombaron P, Collon T, Coëtmeur D, Dayen C, Debieuvre D, Goupil F, Le Treut J, Martin F, Molinier O, Asselain B, Zureik M, Blanchon F.

Rev Pneumol Clin. 2010 Dec;66(6):375-82. doi: 10.1016/j.pneumo.2010.08.001. Epub 2010 Dec 3. French.

PMID:
21167448
45.

Hospital admissions related to acute exacerbations of chronic obstructive pulmonary disease in France, 1998-2007.

Fuhrman C, Roche N, Vergnenègre A, Zureik M, Chouaid C, Delmas MC.

Respir Med. 2011 Apr;105(4):595-601. doi: 10.1016/j.rmed.2010.11.014. Epub 2010 Dec 3.

46.

[Chronic obstructive pulmonary disease (COPD) in the elderly].

Orvoen-Frija E, Benoit M, Catto M, Chambouleyron M, Duguet A, Emeriau JP, Ferry M, Hayot M, Jeandel C, Morize V, Nassih K, Ouksel H, Piette F, Prefaut C, Roche N, de Wazieres B, Zureik M.

Rev Mal Respir. 2010 Oct;27(8):855-73. doi: 10.1016/j.rmr.2010.08.005. Review. French.

PMID:
20965401
47.

[Intrahospital mortality during acute exacerbations of COPD. Study EABPCO-CPHG of the College of the Lung specialists of General hospitals (CPHG)].

Chavaillon JM, Lerousseau L, David P, Martin F, Lamour C, Beraud A, Sleiman C, Debieuvre D, Just N, Senechal F, Camuset J, Mornet M, Fesq G, Zureik M, Roche N, Blanchon F, Piquet J.

Rev Mal Respir. 2010 Sep;27(7):709-16. doi: 10.1016/j.rmr.2010.06.020. Epub 2010 Aug 2. French.

PMID:
20863971
48.

Associations between dietary patterns and arterial stiffness, carotid artery intima-media thickness and atherosclerosis.

Kesse-Guyot E, Vergnaud AC, Fezeu L, Zureik M, Blacher J, Péneau S, Hercberg S, Galan P, Czernichow S.

Eur J Cardiovasc Prev Rehabil. 2010 Dec;17(6):718-24. doi: 10.1097/HJR.0b013e32833a197f.

PMID:
20431391
49.

[Acute COPD exacerbations in women: EABPCO-CPHG study by the College of general hospital pneumologists].

Moncelly L, Maurer C, Roche N, Zureik M, Chavaillon JM, Quieffin J, Calvaire JR, Louerat C, Strecker A, Mathieu JP, Salmon O, Karimo A, Bonnefoy P, Tanguy B, Talbi S, Blanchon F, Piquet J.

Rev Pneumol Clin. 2010 Apr;66(2):107-19. doi: 10.1016/j.pneumo.2009.08.013. Epub 2010 Feb 18. French.

PMID:
20413046
50.

[Characteristics and management of acute exacerbations of COPD in hospital. EABPCO-CPHG study by the college of general hospital respiratory physicians].

Piquet J, Chavaillon JM, David P, Martin F, Braun D, Ferrer Lopez P, Chemery L, Bénichou-Flurin M, Goupil F, Le Poulain-Doubliez M, Arvin-Berod C, Moncelly L, Lebas FX, Maurer C, Dujon C, Mornet M, Roche N, Zureik M, Blanchon F.

Rev Mal Respir. 2010;27(1):19-29. doi: 10.1016/j.rmr.2009.11.007. Epub 2009 Dec 16. French.

PMID:
20146948

Supplemental Content

Loading ...
Support Center